RegulatoryApr 22, 2026, 05:02 PM
GLSI non-compliant with Nasdaq for late 2025 10-K filing
AI Summary
Greenwich LifeSciences received a notice from Nasdaq on April 16, 2026, indicating non-compliance with Listing Rule 5250(c)(1) due to the delayed filing of its Annual Report on Form 10-K for the fiscal year ended December 31, 2025. This notice does not immediately affect the listing or trading of the company's common stock. The company intends to file its Form 10-K as soon as possible, collaborating with both its auditors responsible for the 2024 and 2025 periods.
Key Highlights
- Received Nasdaq non-compliance notice on April 16, 2026.
- Violated Nasdaq Listing Rule 5250(c)(1) for late 2025 10-K.
- No immediate effect on GLSI stock listing or trading.
- Company plans to file 2025 10-K as soon as possible.
Price Impact
More from GLSI